Commentwww.thelancet.com Vol 396 July 18, 2020 145In patients having cardiac and non-cardiac surgery, new-onset postoperative atrial fibrillation and postoperative delirium have been associated with several adverse long-term outcomes, including increased cardiovascular, renal, and cerebral complications, worsened postoperative cognitive function, increased mortality, longer length of stay in hospital, and increased medical costs.1–3 Identifying effective therapies and modifiable factors that might reduce the incidence of postoperative atrial fibrillation and postoperative delirium is paramount
The evolving clinical use of dexmedetomidine / Bilotta, F.; Pugliese, F.. - In: THE LANCET. - ISSN 0140-6736. - 396:10245(2020), pp. 145-147. [10.1016/S0140-6736(20)30902-8]
The evolving clinical use of dexmedetomidine
Bilotta F.;Pugliese F.
2020
Abstract
Commentwww.thelancet.com Vol 396 July 18, 2020 145In patients having cardiac and non-cardiac surgery, new-onset postoperative atrial fibrillation and postoperative delirium have been associated with several adverse long-term outcomes, including increased cardiovascular, renal, and cerebral complications, worsened postoperative cognitive function, increased mortality, longer length of stay in hospital, and increased medical costs.1–3 Identifying effective therapies and modifiable factors that might reduce the incidence of postoperative atrial fibrillation and postoperative delirium is paramount| File | Dimensione | Formato | |
|---|---|---|---|
|
Bilotta_Evolving-use-dexmedetomidine_2020.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
307.37 kB
Formato
Adobe PDF
|
307.37 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
